1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D1722C92F0745C3A00258C1500494EE7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/optimizing-pharma-launch-budgets-best-practices-report-reveals-key-insights?opendocument
18
19opendocument
2018.97.9.169
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






Optimizing Pharma Launch Budgets: Best Practices, LLC Report Reveals Key Insights

CHAPEL HILL, N.C., Jan. 17, 2025/ -- Inefficient budget allocation is a key driver of product launch failures in the highly competitive pharmaceutical industry. To keep pace and ensure a successful launch, launch leaders need to devise strategic budget planning strategies.

Best Practices, LLC has released a benchmarking study titled "https://www.best-in-class.com/rw436.htm">Winning Necessary Resources for a Successful Product Launch," offering critical insights into optimizing launch budgets for maximum success.

The report provides comprehensive benchmarks for resource allocation across 12 essential activities over the four years leading to a launch. Insights are drawn from 48 commercial leaders representing 38 top pharmaceutical and biotech companies.

According to the study, organizations allocate:

  • 30% of their budget three years before launch
  • 24% two years before launch
  • 11% in the year leading up to launch
  • 5% during the launch year

These benchmarks are vital for ensuring resources are allocated effectively across clinical trials, regulatory approvals, marketing campaigns, and more.

The report’s focus areas include:

  • Launch Investment Benchmarks
  • Total Product Launch Investment By Year
  • Launch Activities
  • Launch Staffing Benchmarks
  • The Influence of Market Archetypes on Launch Resourcing
  • Launch Activities Timing

For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw436.htm


Pressed for time? A short video summary of Part 1 of the Pharma Launch Success Series:

 


 

 

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

For Media Inquiries:

Email: psingh@bestpracticesllc.com

Website: https://www.best-in-class.com